Carl Byrnes
Stock Analyst at Northland Capital Markets
(2.33)
# 2,666
Out of 4,996 analysts
25
Total ratings
50%
Success rate
10.73%
Average return
Main Sectors:
Stocks Rated by Carl Byrnes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SNWV SANUWAVE Health | Initiates: Outperform | $55 | $34.40 | +59.88% | 1 | Sep 3, 2025 | |
| BWAY BrainsWay | Maintains: Outperform | $15 → $19 | $14.66 | +29.60% | 4 | Aug 14, 2025 | |
| BLFS BioLife Solutions | Maintains: Outperform | $28 → $31 | $24.70 | +25.51% | 2 | Jan 8, 2025 | |
| TLSI TriSalus Life Sciences | Initiates: Outperform | $13 | $4.70 | +165.96% | 1 | Oct 25, 2024 | |
| MDAI Spectral AI | Initiates: Outperform | $6 | $2.10 | +186.40% | 1 | Aug 12, 2024 | |
| COCH Envoy Medical | Initiates: Outperform | n/a | $0.78 | - | 1 | Dec 21, 2023 | |
| AMRN Amarin Corporation | Maintains: Market Perform | $40 → $25 | $16.00 | +56.25% | 1 | Jul 19, 2023 | |
| CDIO Cardio Diagnostics Holdings | Initiates: Outperform | $240 | $4.07 | +5,796.81% | 1 | May 22, 2023 | |
| VTVT vTv Therapeutics | Maintains: Outperform | $60 → $80 | $22.40 | +257.22% | 4 | Aug 17, 2022 | |
| MDXG MiMedx Group | Initiates: Outperform | $23 | $6.94 | +231.41% | 3 | Jul 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $30 → $24 | $2.65 | +805.66% | 4 | May 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $2,000 | $1.74 | +114,842.53% | 1 | Oct 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $1.21 | - | 1 | Sep 27, 2017 |
SANUWAVE Health
Sep 3, 2025
Initiates: Outperform
Price Target: $55
Current: $34.40
Upside: +59.88%
BrainsWay
Aug 14, 2025
Maintains: Outperform
Price Target: $15 → $19
Current: $14.66
Upside: +29.60%
BioLife Solutions
Jan 8, 2025
Maintains: Outperform
Price Target: $28 → $31
Current: $24.70
Upside: +25.51%
TriSalus Life Sciences
Oct 25, 2024
Initiates: Outperform
Price Target: $13
Current: $4.70
Upside: +165.96%
Spectral AI
Aug 12, 2024
Initiates: Outperform
Price Target: $6
Current: $2.10
Upside: +186.40%
Envoy Medical
Dec 21, 2023
Initiates: Outperform
Price Target: n/a
Current: $0.78
Upside: -
Amarin Corporation
Jul 19, 2023
Maintains: Market Perform
Price Target: $40 → $25
Current: $16.00
Upside: +56.25%
Cardio Diagnostics Holdings
May 22, 2023
Initiates: Outperform
Price Target: $240
Current: $4.07
Upside: +5,796.81%
vTv Therapeutics
Aug 17, 2022
Maintains: Outperform
Price Target: $60 → $80
Current: $22.40
Upside: +257.22%
MiMedx Group
Jul 26, 2021
Initiates: Outperform
Price Target: $23
Current: $6.94
Upside: +231.41%
May 5, 2021
Maintains: Market Perform
Price Target: $30 → $24
Current: $2.65
Upside: +805.66%
Oct 22, 2018
Initiates: Outperform
Price Target: $2,000
Current: $1.74
Upside: +114,842.53%
Sep 27, 2017
Initiates: Outperform
Price Target: n/a
Current: $1.21
Upside: -